Morgan Stanley’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.51K | Buy |
|
|||||
|
2025
Q1 | $847 | Sell |
|
|||||
|
2024
Q4 | $9.69K | Sell |
|
|||||
|
2024
Q3 | $14.3K | Buy |
|
|||||
|
2024
Q2 | $12.4K | Sell |
|
|||||
|
2024
Q1 | $30.6K | Sell |
|
|||||
|
2023
Q4 | $122K | Buy |
|
|||||
|
2023
Q3 | $65.6K | Buy |
|
|||||
|
2023
Q2 | $31.8K | Sell |
|
|||||
|
2023
Q1 | $154K | Buy |
|
|||||
|
2022
Q4 | $27.8K | Sell |
|
|||||
|
2022
Q3 | $40K | Sell |
|
|||||
|
2022
Q2 | $61K | Buy |
|
|||||
|
2022
Q1 | $48K | Sell |
|
|||||
|
2021
Q4 | $107K | Sell |
|
|||||
|
2021
Q3 | $379K | Buy |
|
|||||
|
2021
Q2 | $284K | Buy |
|